Back to Savant Capital, LLC Savant Capital, LLC

ADPTADPT

Showing 8 of 12 quarters

Position history for Savant Capital, LLCSavant Capital, LLC's holdings in ADAPTIVE BIOTECHNOLOGIES

No. Savant Capital exited its ADPT (Adaptive Biotechnologies) position in Q2 2026. Its Q1 2026 13F listed 16,651 shares worth $231,116. Savant Capital first reported ADPT in Q3 2023 and held it in 11 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$175,207

Total Shares Change

-34,220

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$21.45
0
2026-Q1
Increased
16,651
+0.9%
$231,1160.0%$16.08
23
2025-Q4
Increased
16,497
+0.0%
$267,9120.0%$16.42
23
2025-Q3
Unchanged
16,493
0.0%
$246,7360.0%$13.46
0
2025-Q2
Unchanged
16,493
0.0%
$192,1440.0%$11.79
0
2025-Q1
Decreased
16,493
-51.8%
$122,5430.0%$7.67
0
2024-Q4
Increased
34,221
0.0%
$205,1550.0%$6.11
23
2024-Q3
Unchanged
34,220
0.0%
$175,2070.0%$5.00
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used